DENTAL IMPLANT SYSTEM COMPONENT HAVING A COATING

• US 20080014557A1
• Filed: 07/16/2007
• Published: 01/17/2008
• Est. Priority Date: 07/17/2006
• Status: Abandoned Application

• Current Assignee: Heraeus Kulzer GmbH (Mitsui Chemicals)
• Original Assignee: Heraeus Kulzer GmbH (Mitsui Chemicals)
• Inventors: MARTINOVIC, SANDRA, KUHN, KLAUS-DIETER, VOGT, SEBASTIAN
• Application Number:
  US11/778,191
• Publication Number:
  US 20080014557A1
• Time in Patent Office: Days
• US Class Current: 433/201.1
• CPC Class Codes: A61C 8/0012 characterised by the material or composition, e.g. ceramics, surface layer, metal alloy use of specific materials A61K6/00
• CPC Class Codes: A61L 2300/206 Biguanides, e.g. chlorohexidine
• CPC Class Codes: A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
• CPC Class Codes: A61L 2300/41 Anti-inflammatory agents, e.g. NSAIDs
• CPC Class Codes: A61L 2300/45 Mixtures of two or more drugs, e.g. synergistic mixtures
• CPC Class Codes: A61L 2300/606 Coatings
• CPC Class Codes: A61L 2430/12 for dental implants or prostheses
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence

Abstract

A dental implant system component having a coating made of an only slightly water-soluble chlorhexidine fatty acid salt, in which one or more antiphiogistics and/or one or more steroids and/or one or more prostaglandins and/or one or more bisphosphonates and/or one or more statins are dissolved.

Claims

1. Dental implant system component having a coating made of an only slightly water-soluble chlorhexidine fatty acid salt, in which one or more antiphlogistics and/or one or more steroids and/or one or more prostaglandins and/or one or more bisphosphonates and/or one or more statins are dissolved.

2. Dental implant system component according to claim 1, wherein the chlorhexidine fatty acid salt is selected from the group consisting of chlorhexidine laurate, chiorhexidine myristate, chiorhexidine palmitate and chlorhexidine stearate.

3. Dental implant system component according to claim 1, wherein the coating reacts alkaline or pH-neutral in water.

4. Dental implant system component according to claim 1, wherein the coating contains one or more dissolved antiphlogistics selected from the group consisting of ibuprofen, indomethacin and diclofenac.

5. Dental implant system component according to claim 4, wherein the antiphlogistics are provided in their acid form.

6. Dental implant system component according to claim 1, wherein the coating contains one or more dissolved steroids selected from the group consisting of corticosteroids and estrogens.

7. Dental implant system component according to claim 6, wherein the steroids are selected from the group consisting of triamcinolone, dexamethasone and estradiol.

8. Dental implant system component according to claim 1, wherein the coating contains dissolved prostaglandin E2.

9. Dental implant system component according to claim 1, wherein the coating contains dissolved aledronate.

10. Dental implant system component according to claim 9, wherein the aledronate is provided in its acid form.

11. Dental implant system component according to claim 1, wherein the coating contains one or more dissolved statins selected from the group consisting of lovastatin and simvastatin.

12. An oral care method comprising inserting a dental implant system component according to claim 1 into jawbone.